CURIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.77 USD | -1.60% |
|
-7.40% | +15.84% |
| Feb. 09 | HC Wainwright Adjusts Price Target on Curis to $26 From $51, Maintains Buy Rating | MT |
| Feb. 08 | Curis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Curis, Inc.
a.4K0QDzpCsbh2C79LgkTx6_CdHVlT5drESv8OUmrwfM0.2McmaFhvyJVAYIsezzLFgaOpKxs73b2RFYZ-Ph7CJPqG6lVbUAbByztIjw~028a40ddef0768ba264f48d1e3cfeb74
Upcoming events on Curis, Inc.
Past events on Curis, Inc.
| 2024-04-08 12:45 pm | Needham Healthcare Conference |
| 2024-02-08 08:30 am | Q4 2023 Earnings Call |
| 2024-02-08 08:00 am | Q4 2023 Earnings Release |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Abstract No - 4497 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 3143 |
| 2023-12-10 09:00 pm | American Society of Hematology Meeting - Abstract No - 2924 |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 08:00 am | Q3 2023 Earnings Release |
| 2023-09-28 | Reverse Split: 1 of 20 |
| 2023-09-27 09:10 am | Cantor Global Healthcare Conference |
| 2023-09-26 10:00 am | Extraordinary Shareholders Meeting |
| 2023-09-22 09:00 am | IRAK4 Symposium |
| 2023-09-12 08:30 am | H.C. Wainwright Global Investment Conference |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:01 pm | Q2 2023 Earnings Release |
| 2023-05-23 10:00 am | Annual General Meeting |
| 2023-05-04 04:30 pm | Q1 2023 Earnings Call |
| 2023-05-04 04:01 pm | Q1 2023 Earnings Release |
| 2023-04-20 02:15 pm | Needham Healthcare Conference |
| 2023-04-05 12:00 pm | Cantor The Future of Oncology Virtual Symposium - Panel |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 10,8 10,6 1.96% | 10,6 10,7 -0.25% | 10,2 10,4 -2.56% | 10,0 10,3 -2.9% | 8,35 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -41,9 -40,0 -4.77% | -52,8 -54,0 2.25% | 0,00 0,00 - | -49,3 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -24,9 -23,8 -4.58% | -42,1 -40,4 -4.21% | -53,0 -54,0 1.75% | -48,3 -48,1 -0.49% | -50,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -29,9 -28,9 -3.37% | -45,4 -43,8 -3.77% | -56,7 -57,2 0.96% | -47,4 -48,7 2.6% | -48,8 |
|
Net income Million USD | Released Forecast Spread | -32,1 | -29,9 -28,8 -3.81% | -45,4 -43,8 -3.77% | -56,7 -57,6 1.55% | -47,4 -48,7 2.66% | -49,4 |
|
EPS USD | Released Forecast Spread | -19,4 | -12,2 -11,9 -2.23% | -10,0 -9,56 -4.6% | -12,2 -12,4 1.61% | -8,96 -6,85 -30.76% | -6,06 |
| Announcement Date | 19/03/20 | 16/03/21 | 24/02/22 | 13/03/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,14 2,93 6.93% | 2,06 2,55 -19.31% | 2,39 2,72 -12.09% | 2,83 3,16 -10.56% | 2,89 3,26 -11.35% | 2,30 2,59 -11.22% | 2,20 2,51 -12.63% | 2,83 2,63 7.92% | 2,70 3,08 -12.58% | 1,97 | 1,96 | 2,20 | 2,21 | 2,65 |
|
EBITDA Million USD | Released Forecast Spread | -12,5 -11,0 -13.9% | -15,1 -14,6 -3.4% | -15,0 -15,0 -0.05% | -12,5 -15,0 16.37% | -10,1 -12,0 15.6% | -11,6 -9,94 -16.33% | -12,1 -11,6 -4.45% | -12,3 -11,6 -6.44% | -12,4 | -12,6 | -12,1 | -12,3 | -13,8 | |
|
EBIT Million USD | Released Forecast Spread | -12,6 -11,0 -14.57% | -15,1 -13,7 -10.66% | -15,1 -14,5 -3.76% | -12,6 -14,5 13.2% | -10,2 -11,4 10.05% | -11,6 -9,51 -22.33% | -12,1 -11,1 -9.42% | -12,4 -11,5 -7.99% | -12,2 -12,3 0.67% | -12,7 | -12,7 | -12,4 | -12,4 | -12,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,6 -11,9 -14.22% | -16,1 -14,7 -9.36% | -15,9 -15,2 -4.92% | -13,3 -15,4 13.89% | -11,3 -12,0 5.54% | -11,6 -10,5 -10.24% | -12,0 -11,9 -0.46% | -12,2 -12,1 -0.38% | -11,7 -12,1 3.32% | -12,6 | -12,7 | -11,9 | -11,7 | -12,9 |
|
Net income Million USD | Released Forecast Spread | -13,6 -11,9 -14.13% | -16,1 -14,7 -9.37% | -15,9 -15,3 -4.04% | -13,3 -15,5 14.27% | -11,3 -12,3 7.92% | -11,6 -10,5 -10.15% | -12,0 -11,8 -1.55% | -12,2 -12,1 -0.75% | -11,7 -12,3 4.99% | -12,6 | -12,6 | -12,1 | -12,2 | -12,9 |
|
EPS USD | Released Forecast Spread | -3,00 -2,56 -17.19% | -3,60 -3,20 -12.5% | -3,40 -3,30 -3.03% | -2,80 -3,40 17.65% | -2,40 -2,55 5.88% | -2,40 -2,15 -11.63% | -2,40 -2,35 -2.13% | -2,13 -2,36 9.65% | -2,03 -2,12 4.25% | -2,03 | -1,64 | -1,37 | -1,38 | -1,20 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 09/11/22 | 13/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 08/02/24 | - | - | - | - | - |
More events
Past sector events for Curis, Inc.
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRIS Stock
- Calendar Curis, Inc.
